![Peter Kolchinsky](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Kolchinsky
Directeur/Membre du Conseil chez
ARS PHARMACEUTICALS, INC.
Fortune : 106 037 $ au 31/05/2026
Profil
Peter Kolchinsky founded RA Capital Management LP (Private Equity) in 2001, where he is working as Managing Partner, RA Capital Management LP in 2004, where he is working as Managing Partner from 2004, Therapeutics Acquisition Corp.
in 2020, where he worked as Chairman & Chief Executive Officer from 2020 to 2021, and Research Alliance Corp.
II in 2020, where he worked as Chairman & Chief Executive Officer from 2020 to 2022.
Dr. Kolchinsky also founded No Patient Left Behind.
Dr. Kolchinsky also currently works at ARS Pharmaceuticals, Inc., as Independent Director from 2021, Freenome Holdings, Inc., as Director, The American Fertility Association, as Director, Wave Life Sciences USA, Inc., as Director, Wave Life Sciences Ltd., as Independent Director from 2015, Periphagen Holdings, Inc., as Director, ARS Pharmaceuticals Operations, Inc., as Director from 2021, PiloFocus, Inc., as Director, Ivantis, Inc., as Director, Adeo Health Science, Inc., as Director, Enlight Biosciences LLC, as Director, and Forma Therapeutics, Inc., as Director.
Dr. Kolchinsky also formerly worked at G1 Therapeutics, Inc., as Independent Director from 2015 to 2017, Synthorx, Inc., as Independent Director from 2018 to 2020, Lantos Technologies, Inc., as Director, Forma Therapeutics Holdings, Inc., as Independent Non-Executive Director from 2019 to 2022, Calimmune, Inc., as Director, Dicerna Pharmaceuticals, Inc., as Independent Director from 2013 to 2019, ZipLine Medical, Inc., as Director, Medeor Therapeutics, Inc., as Director, Sojournix, Inc., as Director, Cellscape Corp., as Director, Icosavax, Inc., as Independent Director from 2021 to 2024, Global Science & Technology, Inc., as Member-National Academies Board, and National Academies of Sciences, as Member-Global Science & Technology Board from 2009 to 2012.
Dr. Kolchinsky received his undergraduate degree from Cornell University and doctorate degree from Harvard University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
WAVE LIFE SCIENCES LTD. 0,01 % | 27/04/2026 | 16 115 ( 0,01 % ) | 106 037 $ | 31/05/2026 |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Peter Kolchinsky
| Sociétés | Poste | Début |
|---|---|---|
| WAVE LIFE SCIENCES LTD. | Directeur/Membre du Conseil | 01/01/2015 |
| ARS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/08/2021 |
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization. | Directeur Général | 01/09/2004 |
ARS Subsidiary, Inc.
 ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Directeur/Membre du Conseil | 01/08/2021 |
Forma Therapeutics, Inc.
 Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Directeur/Membre du Conseil | - |
Freenome Holdings, Inc.
 Freenome Holdings, Inc. Medical SpecialtiesHealth Technology Operates as an early cancer detection company that develops blood-based screening tests | Directeur/Membre du Conseil | - |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Fondateur | - |
Enlight Biosciences LLC
 Enlight Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops research tools for drug discovery and development | Directeur/Membre du Conseil | - |
Ivantis, Inc.
 Ivantis, Inc. Medical SpecialtiesHealth Technology Develops technology to treat ophthalmic diseases | Directeur/Membre du Conseil | - |
| ░░░░ ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Peter Kolchinsky
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Peter Kolchinsky
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
32
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 32 |
|---|---|
The American Fertility Association
 The American Fertility Association Medical/Nursing ServicesHealth Services Operates as a fertility association for communities | Health Services |
RA Capital Management LP
RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization. | Finance |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
ZipLine Medical, Inc.
 ZipLine Medical, Inc. Medical SpecialtiesHealth Technology Develops non-invasive surgical skin closure devices | Health Technology |
Forma Therapeutics, Inc.
Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Health Technology |
Ivantis, Inc.
Ivantis, Inc. Medical SpecialtiesHealth Technology Develops technology to treat ophthalmic diseases | Health Technology |
Lantos Technologies, Inc.
 Lantos Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops intra-aural 3D ear scanning systems | Electronic Technology |
Forma Therapeutics Holdings, Inc.
 Forma Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes novel therapeutics to transform the patient living | Health Technology |
Wave Life Sciences Ltd.
 Wave Life Sciences Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA oligonucleotides medicines | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Science & Technology, Inc.
 Global Science & Technology, Inc. Miscellaneous Commercial ServicesCommercial Services Provides science and engineering, information technology, professional and technical services to federal government clients | Commercial Services |
Enlight Biosciences LLC
Enlight Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops research tools for drug discovery and development | Health Technology |
Calimmune, Inc.
 Calimmune, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Cellscape Corp.
 Cellscape Corp. Data Processing ServicesTechnology Services Provides data analytics services | Technology Services |
National Academies of Sciences
 National Academies of Sciences Miscellaneous Commercial ServicesCommercial Services Provides science, technology and health policy advisory services | Commercial Services |
G1 Therapeutics, Inc.
 G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Periphagen Holdings, Inc.
 Periphagen Holdings, Inc. Financial ConglomeratesFinance Operates as an investment holding company with an interest in drug developers | Finance |
PiloFocus, Inc.
 PiloFocus, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes cosmetic surgical instruments | Health Technology |
Synthorx, Inc.
 Synthorx, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that uses synthetic biology to discover and develop protein therapeutics | Health Technology |
Adeo Health Science, Inc.
 Adeo Health Science, Inc. Food: Major DiversifiedConsumer Non-Durables Operates as research-driven food company which develops and sells organic baby food | Consumer Non-Durables |
Wave Life Sciences USA, Inc.
 Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Provides nucleic acid therapeutics | Utilities |
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for organ transplant recipients | Health Technology |
Sojournix, Inc.
 Sojournix, Inc. BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Health Technology |
Freenome Holdings, Inc.
Freenome Holdings, Inc. Medical SpecialtiesHealth Technology Operates as an early cancer detection company that develops blood-based screening tests | Health Technology |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Health Technology |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Finance |
Icosavax, Inc.
 Icosavax, Inc. BiotechnologyHealth Technology Develops vaccines for infectious disease | Health Technology |
Therapeutics Acquisition Corp.
 Therapeutics Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Research Alliance Corp. II
 Research Alliance Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
No Patient Left Behind
 No Patient Left Behind No Patient Left Behind is a non-profit company dedicated to ensuring that all patients have access to necessary medications and healthcare services. The company is based in Washington, DC. It focuses on advocating for policy changes and providing resources to help patients navigate the healthcare system. Through its initiatives, No Patient Left Behind aims to eliminate barriers to healthcare and promote equitable treatment for all individuals. The company was founded by Peter Kolchinsky. | |
ARS Pharmaceuticals, Inc.
 ARS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
